Question · asked by 1 review

Adults: formoterol/ICS vs salmeterol/ICS: Asthma‐related non‐fatal serious adverse events

Adults: formoterol/ICS showed no clear difference in asthma‐related non‐fatal serious adverse events ‐… compared with salmeterol/ICS (low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Adults: formoterol/ICS vs salmeterol/ICS
Asthma‐related non‐fatal serious adverse events ‐ formoterol/budesonide vs salmeterol/fluticasone · adults, chronic asthma: asthma‐related serious adverse events
Adults: formoterol/ICS showed no clear difference in asthma‐related non‐fatal serious adverse events ‐… compared with salmeterol/ICS (low certainty).
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and… (2021) · Cochrane Headline outcomes only
OR 0.69 [0.37, 1.26]7 studies · 5935 participantsLow
Adults: formoterol/ICS vs salmeterol/ICS
Asthma‐related non‐fatal serious adverse events ‐ formoterol/beclomethasone vs salmeterol/fluticasone · adults, chronic asthma: asthma‐related serious adverse events
It is very uncertain whether adults: formoterol/ICS changes asthma‐related non‐fatal serious adverse events ‐… compared with salmeterol/ICS (very low certainty).
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and… (2021) · Cochrane Headline outcomes only
OR 1.01 [0.06, 16.24]5 studies · 1510 participantsVery low
Adults: formoterol/ICS vs salmeterol/ICS
Asthma related non‐fatal serious adverse events ‐ formoterol/mometasone v's salmeterol/fluticasone · adults, chronic asthma: asthma‐related serious adverse events
It is very uncertain whether adults: formoterol/ICS changes asthma related non‐fatal serious adverse events ‐… compared with salmeterol/ICS (very low certainty).
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and… (2021) · Cochrane Headline outcomes only
OR 7 [0.14, 353.37]1 study · 722 participantsVery low
Adults: formoterol/ICS vs salmeterol/ICS
Asthma‐related non‐fatal serious adverse events ‐ formoterol/fluticasone vs salmeterol/fluticasone · adults, chronic asthma: asthma‐related serious adverse events
It is very uncertain whether adults: formoterol/ICS changes asthma‐related non‐fatal serious adverse events ‐… compared with salmeterol/ICS (very low certainty).
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and… (2021) · Cochrane Headline outcomes only
OR 0.05 [0, 3.1]2 studies · 293 participantsVery low
Adults: formoterol/ICS vs salmeterol/ICS
Asthma‐related non‐fatal serious adverse events ‐ formoterol/budesonide vs salmeterol/budesonide · adults, chronic asthma: asthma‐related serious adverse events
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and… (2021) · Cochrane Headline outcomes only
no estimate extracted1 study · 229 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for…
2021 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.